OBJECTIVE AND DESIGN: The aim of this study was to study the effect of caveolin-1 on the cytosolic phospholipase A2 (cPLA2), p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor kappaB (NF-kappaB) in mouse lung alveolar type-1 cells' (AT-1 cells) inflammatory response induced by LPS. MATERIALS AND METHODS: Gene clone technique was used to over-express caveolin-1 in AT-1 cells by lentivirus vector. The level of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), cPLA2, p38 MAPK and NF-kappaB was measured by ELISA, western blotting and EMSA. TREATMENT: AT-1 cells were treated with LPS. RESULTS: Over-expression of caveolin-1 not only increased the production of pro-inflammatory cytokine TNF-alpha and IL-6, but also enhanced the expression of the cPLA2, p38 MAPK, and NF-kappaB. CONCLUSIONS: Our data demonstrated that over-expression of caveolin-1 aggravates the AT-1 injury induced by LPS, involving in modulation of the cPLA2 mediated by the cPLA2/p38 MAPK pathway.
OBJECTIVE AND DESIGN: The aim of this study was to study the effect of caveolin-1 on the cytosolic phospholipase A2 (cPLA2), p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor kappaB (NF-kappaB) in mouse lung alveolar type-1 cells' (AT-1 cells) inflammatory response induced by LPS. MATERIALS AND METHODS: Gene clone technique was used to over-express caveolin-1 in AT-1 cells by lentivirus vector. The level of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), cPLA2, p38 MAPK and NF-kappaB was measured by ELISA, western blotting and EMSA. TREATMENT: AT-1 cells were treated with LPS. RESULTS: Over-expression of caveolin-1 not only increased the production of pro-inflammatory cytokine TNF-alpha and IL-6, but also enhanced the expression of the cPLA2, p38 MAPK, and NF-kappaB. CONCLUSIONS: Our data demonstrated that over-expression of caveolin-1 aggravates the AT-1 injury induced by LPS, involving in modulation of the cPLA2 mediated by the cPLA2/p38 MAPK pathway.
Authors: P E Scherer; R Y Lewis; D Volonte; J A Engelman; F Galbiati; J Couet; D S Kohtz; E van Donselaar; P Peters; M P Lisanti Journal: J Biol Chem Date: 1997-11-14 Impact factor: 5.157
Authors: Takashige Miyahara; Kazutoshi Hamanaka; David S Weber; Mircea Anghelescu; James R Frost; Judy A King; James C Parker Journal: J Appl Physiol (1985) Date: 2007-11-15
Authors: Jerry A Nick; Scott K Young; Patrick G Arndt; Jonathan G Lieber; Benjamin T Suratt; Katie R Poch; Natalie J Avdi; Ken C Malcolm; Christian Taube; Peter M Henson; G Scott Worthen Journal: J Immunol Date: 2002-11-01 Impact factor: 5.422
Authors: Yang Jin; Hong Pyo Kim; Minli Chi; Emeka Ifedigbo; Stefan W Ryter; Augustine M K Choi Journal: Am J Respir Cell Mol Biol Date: 2008-03-06 Impact factor: 6.914
Authors: Yang Jin; Seon-Jin Lee; Richard D Minshall; Augustine M K Choi Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-11-19 Impact factor: 5.464
Authors: Kerry L Inder; Yu Zi Zheng; Melissa J Davis; Hyeongsun Moon; Dorothy Loo; Hien Nguyen; Judith A Clements; Robert G Parton; Leonard J Foster; Michelle M Hill Journal: Mol Cell Proteomics Date: 2011-10-26 Impact factor: 5.911
Authors: Jennifer J P Collins; Steffen Kunzmann; Elke Kuypers; Matthew W Kemp; Christian P Speer; John P Newnham; Suhas G Kallapur; Alan H Jobe; Boris W Kramer Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-01-18 Impact factor: 5.464
Authors: Nan Wang; Dan Zhang; Gengyun Sun; Hong Zhang; Qinghai You; Min Shao; Yang Yue Journal: Drug Des Devel Ther Date: 2015-08-28 Impact factor: 4.162